UroGen Pharma (UR8.STU) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-0.41
-0.41
-0.4
-0.4

Details

Expected EPS
-0.410554738
Actual EPS
-0.39997
Surprise EPS
0.01
Surprise Percent
+2.58%

Description

UroGen Pharma (UR8.STU) has reported earnings of -0.39997 per share for Q2 2026.

0 Comments

Share your thoughts